Shengtai Pharmaceutical Inc  

(Public, OTCMKTS:SGTI)   Watch this stock  
Find more results for SGTI
0.0000 (0.00%)
Feb 8 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.03 - 0.13
Open     -
Vol / Avg. 0.00/172.00
Mkt cap 287,550.00
P/E     -
Div/yield     -
EPS     -
Shares 9.58M
Beta 2.00
Inst. own 0%

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 0.21% 0.60%
Operating margin 2.99% 3.07%
EBITD margin - 7.57%
Return on average assets 0.23% -
Return on average equity 0.66% -
Employees 733 -
CDP Score - -


Changda Road East Development District, Changle County
+86-536-2182777 (Phone)

Website links


Shengtai Pharmaceutical, Inc. (Shengtai), through its wholly owned subsidiary, Weifang Shengtai Pharmaceutical Inc., is a producer of pharmaceutical-grade glucose in China. The Company's products include pharmaceutical-grade glucose or dextrose, used for medical purposes, as well as other glucose and cornstarch products used for the food and beverage industry, and for industrial productions in China. The Company's glucose series include dextrose monohydrate (DMH), dextrose anhydrous, oral glucose dextrin and rough glucose for other processing purposes. Its starch series include pharmaceutical starch and edible corn starch. The Company's customers include healthcare institutions, food and beverage companies, pharmaceutical companies, medical supply exporters and medical supply. The Company also exports its products to approximately 70 different countries overseas, such as Japan, Singapore, Korea, Australia, Russia and India.

Officers and directors

Qingtai Liu Chairman of the Board, Chief Executive Officer
Age: 55
Yongqiang Wang Chief Financial Officer, Director
Age: 43
Tao Jin Independent Director
Age: 46
Lawrence Lee Independent Director
Age: 50
Yaojun Liu Independent Director
Age: 36